Medication info
Atorcell S Tablets 20 mg (Atorvastatin Calcium Hydrate)

Atorcell S Tablets 20 mg (Atorvastatin Calcium Hydrate)

Prescription medicationTablet
Ingredient · strength
Atorvastatin Calcium Hydrate›21.7mg / 1 tablet
Manufacturer / importer
Telcon RF Pharmaceutical Co., Ltd.
Appearance
White round film-coated tablet
Packaging
100 tablets/bottle, 30 tablets/bottle
Approval status
Active

MFDS item code 201907848 · Approved 2019.11.11

Summary

Main use
Improvement of hyperlipidemia; prevention of cardiovascular diseases (such as myocardial infarction and stroke)
Who uses it
Adults · Children
Adult dosage
Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. This medicine may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. For patients requiring a greater reduction in LDL cholesterol, treatment may be initiated at 20 mg or 40 mg once daily (40 mg is only for patients requiring a reduction in LDL cholesterol of 45 % or more). This medicine is administered at a dose of 10 ∼ 80 mg once daily. The initial and maintenance doses should be individualized according to the patient's characteristics, taking into account treatment goals and response. Lipid levels should be analyzed within 2 ∼ 4 weeks after starting treatment and/or adjusting the dose, and the dose should be adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, LDL cholesterol is recommended for use when initiating treatment and evaluating the response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor the response to treatment. Patients with homozygous familial hypercholesterolemia The dose of this medicine is 10 ∼ 80 mg once daily. It should be administered in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are not available. ○ Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL-cholesterol-lowering effect; therefore, no dose adjustment is necessary. ○ Older adults: Efficacy and safety in patients aged 70 years or older are generally similar to those in the usual adult patient population.
Children's dosage
Pediatric patients with heterozygous familial hypercholesterolemia (10 ∼ 17 years): The recommended initial dose of this medicine is 10 mg once daily, and the recommended maximum dose is 20 mg daily (there are no clinical data on doses of this medicine greater than 20 mg in pediatric patients). Adjust the dose as appropriate according to the recommended treatment goals for each patient. Adjustments should be made at intervals of 4 weeks or longer.

Ingredients

Manufacturer
Telcon RF Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of hyperlipidemia; prevention of cardiovascular diseases (such as myocardial infarction and stroke)

  • Myocardial infarction
  • stroke
  • chronic stable angina
  • retinopathy
  • albuminuria
  • congestive heart failure
  • hyperlipidemia
  • hypercholesterolemia
  • dyslipidemia
  • abnormal beta-lipoproteinemia
  • elevated serum triglycerides
  • familial hypercholesterolemia
View approved original text

This medication reduces the risk of cardiovascular events such as myocardial infarction, stroke, the need for vascular surgery, and angina in patients with various risk factors for cardiovascular disease. It is particularly effective in adults with risk factors such as older age, smoking, hypertension, low HDL cholesterol levels, and diabetes, as well as in patients with type 2 diabetes. Additionally, for patients with clinical evidence, it decreases the risk of hospitalization due to not only myocardial infarction and stroke but also congestive heart failure. This drug is also used to treat hyperlipidemia, specifically lowering blood cholesterol and triglycerides in patients with primary hypercholesterolemia and dyslipidemia, while increasing HDL cholesterol. It is used as an adjunct to dietary therapy in children with heterozygous familial hypercholesterolemia at high risk of heart disease. Overall, this medication effectively improves the risk of cardiovascular disease.

Dosage and Administration

Adult dosage

Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. This medicine may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. For patients requiring a greater reduction in LDL cholesterol, treatment may be initiated at 20 mg or 40 mg once daily (40 mg is only for patients requiring a reduction in LDL cholesterol of 45 % or more). This medicine is administered at a dose of 10 ∼ 80 mg once daily. The initial and maintenance doses should be individualized according to the patient's characteristics, taking into account treatment goals and response. Lipid levels should be analyzed within 2 ∼ 4 weeks after starting treatment and/or adjusting the dose, and the dose should be adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, LDL cholesterol is recommended for use when initiating treatment and evaluating the response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor the response to treatment. Patients with homozygous familial hypercholesterolemia The dose of this medicine is 10 ∼ 80 mg once daily. It should be administered in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are not available. ○ Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL-cholesterol-lowering effect; therefore, no dose adjustment is necessary. ○ Older adults: Efficacy and safety in patients aged 70 years or older are generally similar to those in the usual adult patient population.

Children's dosage

Pediatric patients with heterozygous familial hypercholesterolemia (10 ∼ 17 years): The recommended initial dose of this medicine is 10 mg once daily, and the recommended maximum dose is 20 mg daily (there are no clinical data on doses of this medicine greater than 20 mg in pediatric patients). Adjust the dose as appropriate according to the recommended treatment goals for each patient. Adjustments should be made at intervals of 4 weeks or longer.

Precautions

This medication may present symptoms of muscle abnormalities, so if there is severe muscle pain or weakness or if creatine kinase levels rise significantly, use should be discontinued immediately. Patients at higher risk for severe myopathy or rhabdomyolysis should temporarily discontinue or stop using this medication. This drug should not be used in women who are pregnant or have specific diseases, children under 10 years old, and patients with certain liver diseases. Patients with alcohol dependence or impaired liver function should use this drug cautiously, and it is advised to check muscle enzyme levels before treatment in patients at risk of myopathy. If symptoms such as fatigue, muscle pain, or fever appear during the use of this medication, consult a doctor promptly. Also, as this drug can affect liver function, regular liver function tests are necessary, and if symptoms of hepatitis or jaundice appear, its use should be discontinued. Women of childbearing age should use appropriate contraceptive methods during treatment and should stop taking it if pregnancy occurs. This drug may interact with other medications, particularly specific antibiotics, antifungals, HIV treatments, and grapefruit juice, so caution is advised when used concomitantly. Elderly patients or those with reduced renal function are at increased risk for myopathy and should take extra precautions when using this drug. There is no specific antidote for overdose, thus treatment should be symptomatic, checking liver function and muscle enzyme tests to monitor the condition. Keep this medication out of the reach of children and store it safely in its original container.

Side effects

Apathy, lethargy, chest pain, peripheral edema, fatigue, fever, nasopharyngitis, hyperglycemia, hypoglycemia, weight gain, loss of appetite, constipation, abdominal bloating, dyspepsia, nausea, diarrhea, abdominal pain, vomiting, belching, pancreatitis, pharyngitis, laryngitis, nosebleed, insomnia, nightmares, headache, dizziness, paresthesia, sensory loss, taste disturbance, memory loss, peripheral neuropathy, myalgia, arthralgia, limb pain, musculoskeletal pain, muscle cramps, joint swelling, back pain, neck pain, muscle fatigue, rupture-related complications, myopathy, myositis, rhabdomyolysis, tendon disorders, muscle rupture, lupus-like syndrome, immune-mediated necrotizing myopathy, thrombocytopenia, vasculitis, allergic reactions, anaphylaxis, hepatitis, cholestasis, liver failure, blurred vision, visual impairment, tinnitus, hearing loss, urticaria, skin rash, itching, hair loss, angioedema, vascular neurogenic edema, polymorphous erythroderma, mucous membrane pemphigoid, toxic epidermal necrolysis, gynecomastia, abnormal liver function tests, elevated serum CK, positive leukocytes in urine, vomiting, abdominal abnormalities, hepatitis, pancreatitis, cholestasis, cholestatic jaundice, abnormal liver function test results, gastroenteritis, enteritis, dry mouth, rectal bleeding, esophagitis, belching, glossitis, oral ulcers, stomatitis, gallbladder pain, cheilitis, peptic duodenal ulcer, dysphagia, melena, gingival bleeding, postprandial urgency, bronchitis, rhinitis, pneumonia, dyspnea, asthma, sensory disturbances, vertigo, phototoxic reactions, drowsiness, forgetfulness, abnormal dreams, decreased libido, emotional instability, ataxia, torticollis, facial paralysis, hyperkinesia, depression, increased tension, myositis, myopathy, arthritis, bursitis, tenosynovitis, myasthenia gravis, contracture, elevated serum myoglobin, contact dermatitis, dry skin, sweating, acne, eczema, seborrhea, skin ulcers, erectile dysfunction, urinary tract infection, frequent urination, cystitis, hematuria, dysuria, kidney stones, nocturia, epididymitis, fibrocystic breast disease, vaginal bleeding, albuminuria, breast enlargement, cervical discharge, nephritis, urinary incontinence, urinary retention, urgency incontinence, abnormal ejaculation, uterine bleeding, discolored urine, lethargy, vasogenic edema, chest pain, angina, facial swelling, fever, neck stiffness, generalized edema, amblyopia, dry eyes, refractive errors, ocular hemorrhage, hearing loss, glaucoma, taste disturbance, loss of taste, taste distortion, leukopenia, anemia, decreased testosterone, elevated cholinesterase, elevated TSH, elevated ACTH, decreased aldosterone, elevated potassium, elevated BUN, cerebral infarction, palpitations, tachycardia, hyperlipidemia, facial flushing, increased non-protein nitrogen, hyperuricemia, gingival hypertrophy, hypothermia, sleep disorders, memory loss, depression, interstitial lung disease, sexual dysfunction, cognitive impairment, muscle weakness, ocular muscle weakness, elevated AST, fulminant hepatitis, nausea, vomiting, lethargy, muscle pain, muscle weakness, acute renal failure secondary to myoglobinuria, rhabdomyolysis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. It is best to maintain storage temperatures between 1°C and 30°C.

Appearance and packaging

Appearance

White round film-coated tablet

Package unit

100 tablets/bottle, 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.